Literature DB >> 8772302

Epidemiology of enterotoxigenic Escherichia coli-associated diarrheal disease occurring on board U.S. Navy ships visiting Asian ports.

G R Orndorff1, C Lebron.   

Abstract

Diarrhea represents a major health threat to U.S. military forces overseas, especially in developing countries. For military units, this illness can adversely affect combat readiness. USNAMRU-2 investigators joined several U.S. Navy ships to assess the epidemiology of diarrhea illness as a result of port visits to Asia. The primary goals were to enumerate episodes of diarrhea associated with port visits, identify epidemiologic factors leading to illness, and characterize the etiologic agents. Enterotoxigenic Escherichia coli (ETEC) was the most common organism isolated from patients presenting with diarrhea and represented 22% of diarrhea cases. Vomiting and abdominal pain differentiated ETEC from other causes of diarrhea.

Entities:  

Mesh:

Year:  1996        PMID: 8772302

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  4 in total

Review 1.  Preparing patients to travel abroad safely. Part 4: Reducing risk of accidents, diarrhea, and sexually transmitted diseases.

Authors:  R E Thomas
Journal:  Can Fam Physician       Date:  2000-08       Impact factor: 3.275

Review 2.  Virulence regulons of enterotoxigenic Escherichia coli.

Authors:  George P Munson
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Authors:  T S Coster; M K Wolf; E R Hall; F J Cassels; D N Taylor; C T Liu; F C Trespalacios; A DeLorimier; D R Angleberger; C E McQueen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

4.  The Virulence Regulator Rns Activates the Expression of CS14 Pili.

Authors:  Maria Del Rocio Bodero; George Patrick Munson
Journal:  Genes (Basel)       Date:  2016-12-08       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.